Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: A population-based cohort study

Vaccine

Volumn 32, Issue 30, 2014, Pages 3843-3849

  Sung, Li Chin ^a,b   Chen, Chang I ^c,d   Fang, Yu Ann ^d   Lai, Chih Hong ^b   Hsu, Yi Ping ^b   Cheng, Tzu Hurng ^a   Miser, James S ^e   Liu, Ju Chi ^a,b,f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acute coronary syndromes; Chronic obstructive; Cohort studies; Influenza vaccines; Pulmonary disease

Indexed keywords

INFLUENZA VACCINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANEMIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPERTENSION; INFLUENZA; INFLUENZA VACCINATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; TAIWAN; TAIWANESE; URBANIZATION; INFLUENZA, HUMAN; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TAIWAN;

EID: 84922216975     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.064     Document Type: Article

References (41)

1. Vestbo J., Hurd S.S., Agusti A.G., Jones P.W., Vogelmeier C., Anzueto A., et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med 2012, (August). [Epub ahead of print].
2. Center for Disease Control Prevention Deaths: preliminary data for 2009. Natl Vital Stat Rep 2011, 59:4.
3. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine 2006, 3:e442.
4. van Durme Y.M., Verhamme K.M., Stijnen T., van Rooij F.J., Van Pottelberge G.R., Hofman A., et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest 2009, 135(2):368-377.
5. Centers for Disease Control Prevention (CDC) Assessing adult vaccination status at age 50 years. MMWR Morb Mortal Wkly Rep 1995, 44(29):561-563.
6. Ohmit S.E., Monto A.S. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemol 1995, 24:1240-1248.
7. Nafhavi M., Barlas Z., Siadaty S., Naguib S., Mdjid M., Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000, 102(25):3039-3045.
8. Lavallee P., Perchaud V., Gautier-Bertrand M., Grabi D., Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002, 33:513-518.
9. Bridges C.B., Fukuda K., Uyeki T.M., Cox N.J., Singleton J.A., Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2002, 51(RR-3):1-31.
10. Alling D.W., Blackwelder W.C., Stuart-Harris C.H. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol 1981, 113:30-43.
11. Camilli A.E., Robbins D.R., Lebowitz M.D. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991, 133:795-800.
12. Meier C.R., Jick S.S., Derby L.E., Vasilakis C., Jick H. Acute respirator-tract infections and risk of first-time acute myocardial infarction. Lancet 1998, 351:1467-1471.
13. Harskamp R.E., van Ginkel M.W. Acute respiratory tract infections: a potential trigger for the acute coronary syndrome. Ann Med 2008, 40:121-128.
14. Nichol K.L., Nordin J., Mullooly J., Lask R., Filbrand K., Iwane M.K. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003, 348:1322-1332.
15. Udell J.A., Zawi R., Bhatt D.L., Keshtkar-Jahromi M., Gaughran F., Phrommintikul A., et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013, 310(6):1711-1720.
16. Phrommintikul A., Kuanprasert S., Wongcharoen W., Kanjanavanit R., Chaiwarith R., Sukonthasarn A. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 2011, 32(14):1730-1735.
17. Chiu P.J., Chen C.H., Chih Y.C. Effectiveness of the influenza vaccination program for the elderly in Taiwan. Vaccine 2013, 31(4):632-638.
18. Wang C.S., Wang S.T., Lai C.T., Lin L.J., Chou P. Impact of influenza vaccination on major cause-specific mortality. Vaccine 2007, 25:1196-1203.
19. Gwini S.M., Coupland C.A., Siriwardena A.N. The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study. Vaccine 2011, 29(6):1145-1149.
20. D'Agostino R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998, 17(19):2265-2281.
21. Wang Y.C., Lin C.W., Ho Y.T., Huang Y.P., Pan S.L. Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study. PLoS ONE 2013, 8:e68314.
22. Chou F.H., Tsai K.Y., Su C.Y., Lee C.C. The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res 2011, 129(2-3):97-103.
23. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24(8):1159-1169.
24. Sin D.D., Man S.F. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 2005, 83(1):8-13.
25. Sin D.D., Man S.F. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005, 2(1):8-11.
26. Jousilahti P., Vartiainen E., Tuomilehto J., Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996, 348:567-572.
27. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
28. Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., Miller M.A. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 2004, 160:492-502.
29. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., Knothnerus J.A. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994, 272:1661-1665.
30. Hemogenes A.W., Gross P.A. Influenza virus vaccine: a need for emphasis. Semin Respir Infect 1992, 7(1):54-60.
31. Yap F.H., Ho P.L., Lam K.F., Chan P.K., Cheng Y.H., Peiris J.S. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol 2004, 73(4):617-623.
32. Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004, 351:2611-2618.
33. Corrales-Medina V.F., Madjid M., Musher D.M. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010, 10(2):83-92.
34. Naghavi M., Wyde P., Litovsky S., Madjid M., Akhtar A., Naguib S., Siadaty M.S., Sanati S., Casscells W. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003, 107:762-768.
35. Dvorakova A., Poledne R. Influenza: a trigger for acute myocardial infarction. Atherosclerosis 2004, 172:391.
36. Van Lenten B.J., Wagner A.C., Nayak D.P., Hama S., Navab M., Fogelman A.M. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation 2001, 103(18):2283-2288.
37. Badimon L., Storey R.F., Vilahur G. Update on lipids, inflammation and atherothrombosis. Thromb Haemost 2011, 105(Suppl 1):S34-S42.
38. Fazio G.P., Redberg R.F., Winslow T., Schiller N.B. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. J Am Coll Cardiol 1993, 21:144-150.
39. Gurevich V.S., Pleskov V.M., Levaia M.V., Bannikov A.I., Mitrofanova L.B., Urazgil'deeva S.A. Influenza virus infection in progressing atherosclerosis. Kardiologiia 2002, 42(7):21-24.
40. Schwartz S.M., Galis Z.S., Rosenfeld M.E., Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007, 27:705-713.
41. Johnstone J., Loeb M., Teo K.K., Gao P., Dyal L., Liu L., et al. Influenza vaccination and major adverse vascular events in high risk patients. Circulation 2012, 126:278-286.